Polymyositis associated with infliximab treatment for rheumatoid arthritis
暂无分享,去创建一个
K. Kowatari | Y. Mizushima | Y. Wakai | Y. Urata | T. Nitobe
[1] H. Hashimoto,et al. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. , 2006, The Journal of rheumatology.
[2] J. Ballet,et al. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. , 2006, The Journal of rheumatology.
[3] T. Mitsui,et al. Involvement of mitochondria in myasthenia gravis complicated with dermatomyositis and rheumatoid arthritis: a case report , 2005, Acta Neuropathologica.
[4] J. Musial,et al. Polymyositis associated with infliximab treatment for rheumatoid arthritis. , 2003, Rheumatology.
[5] M. Netea,et al. Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations , 2003, European Neurology.
[6] O. Meyer,et al. Anti-TNF-α-induced systemic lupus syndrome , 2003, Clinical Rheumatology.
[7] O. Meyer,et al. Anti-TNF-alpha-induced systemic lupus syndrome. , 2003, Clinical rheumatology.
[8] E. Roddy,et al. Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab. , 2002, Rheumatology.
[9] E. Gromnica-ihle,et al. Clinical and Serological Aspects of Patients with Anti-Jo-1 Antibodies – an Evolving Spectrum of Disease Manifestations , 2000, Clinical Rheumatology.
[10] E. A. Jenkins,et al. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody. , 1993, British journal of rheumatology.